NIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, Nora D. Volkow, M.D., Director

Similar documents
Director s Report to the National Advisory Council on Drug Abuse

Tobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies

Collaborative Research on Addiction at NIH (CRAN) (Formerly known as Functional Integration)

Gene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup. April 17, Organizational Meeting

Planning, Priority Setting, and Budget Development for NIH AIDS Research

California Department of Education. Coordinated School Health and Safety Office. Report to the Tobacco Education and Research Oversight Committee

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

Director s Report to the National Advisory Council on Drug Abuse

Director s Report to the National Advisory Council on Drug Abuse

Marijuana Science Update

The Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director

The NIH SBIR/STTR Program & Universities

NIAAA: Current and Future Priorities. George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health

NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016

Director s Report to the National Advisory Council on Drug Abuse

MARIJUANA: Selected Effects on Brain, Body & Behavior

National Institute on Drug Abuse Strategic Plan on Reducing Health Disparities

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

PCORI s Role in Supporting CER

BD-STEP: Tackling Key Issues Across Cancer Research and Care

NIDA/FDA Collaborations

Science = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse

A Developmental Perspective on the Role of Genes on Substance Use Disorder. Elisa M. Trucco, Ph.D., Florida International University

Ryan White HIV/AIDS Program 2015 Part C and D Consolidation Proposal: Discussion of the Critical Elements for the Funding Opportunity Announcement

Learning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking

American School Health Association

Director s Report to the National Advisory Council on Drug Abuse. Nora D. Volkow, M.D., Director

HEALthy Brain and Child Development (HBCD) Study. Technical Assistance Webinar February 6, 2019

Gaya J. Dowling, Ph.D. Director, ABCD Project Division of Extramural Research, NIDA

Testimony on behalf of the FRIENDS OF NIDA COALITION. Regarding the Fiscal Year 2007 Appropriation for the. National Institute on Drug Abuse

Marijuana is the Most Commonly Used Illicit Drug In the U.S.

An Update on the Interagency Autism Coordinating Committee (IACC) and the IACC Strategic Plan

Fogarty Initiatives for Building Capacity in HIV/AIDS

SBIRT Collaborative: Wednesday, May 11, PM EST Dial-in information: (800) ;

Recommendation 1: Promote Kidney Disease Prevention Research

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Opportunities for Statistical Modeling and Computation at the National Institute of Mental Health (NIMH), NIH

BRP update from the NCI Acting Director

Prevention Can Work. SELECT A TOPIC...

Infectious Disease Bureau Ryan White Services Division. Request For Proposal. Ryan White Services Division Consultant

NIH Office of Research on Women s Health (ORWH)

Society for Prevention Research 2018 Call for Papers Author Abstract Submission Questions. Research Foci

Kevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA. No disclosures

Campus-Community Strategies in Substance Use/Misuse and HIV Prevention Frances M. Harding Director SAMHSA s Center for Substance Abuse Prevention

Pediatric Nih Stroke Scale

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

SAMHSA: A Public Health Agency

Service Improvement - Strategic. Service Improvement - Strategic. Regional Oncology Communications and Health Promotions

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

NIDA Strategic Planning Complex PaFents Workgroup. April 9, 2015

Neuroscience International Funding Opportunities at NINDS & NIH

SAMHSA State/Tribal/Adolescents at Risk Suicide Prevention Grantee Technical Assistance Meeting

National Drug and Alcohol Facts Week: Shatter the Myths in Your School. October 23, 2018

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Drug Abuse & Addiction Research: Progress, Priorities, & Challenges

Washington, DC Washington, DC Services, Education, and Related Agencies Services, Education, and Related Agencies

NIH Toolbox. Technical Manual

SAMHSA FY 2017 Discretionary Grant Forecast

Opportunities in Pain Research with the NIH HEAL Initiative

The NIH STTR Program

Partnerships for Success Grant Overview, Timelines and Questions

Addiction and substance misuse

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000

Identification & Diagnosis of Cryptogenic Stroke What is NINDS/role

Clinical Quality Management Policy Clarification Notice

NIH Initiatives in Nutrition: Roadmap, Strategic Plan

Dietary Supplement Research Portfolio at the NIH, ,2

Testimony of Vaira Harik, Barnstable County Department of Human Services on HB3898 2/9/16

Report. of the Racial/Ethnic Minority Health Disparities Work Group of the National Advisory Council on Drug Abuse

Overview of the NIH. National Institutes of Health (NIH)

GUIDELINES FOR DEVELOPING THREE YEAR STRATEGIC PLANS FOR SUBSTANCE USE DISORDER FOR PREVENTION, TREATMENT, AND RECOVERY SERVICES A SUMMARY

Media Kit. September 2017

SBIRT in SBHCs: A Model for Adolescent Substance Use Prevention

2017 Executive Summary. The Conrad N. Hilton Foundation s Youth Substance Use Prevention and Early Intervention Strategic Initiative


Centers for Disease Control and Prevention s Office on Smoking and Health

April 8, Nora D. Volkow, M.D., Director National Institute on Drug Abuse 6001 Executive Boulevard Bethesda, MD Dear Dr.

Autism: The Federal Effort. Thomas R. Insel, M.D. National Institute of Mental Health NIH/DHHS 12/16/05

NIAAA: Researching Alcohol in America

Washington State PMP Data Mapping Project

CPRIT Overview. Cancer Centers Administrators Forum April 4, 2016

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH

NIAAA UPDATE. Daniel Falk, Ph.D. Brett Hagman, Ph.D. Robert Huebner, Ph.D. Division of Treatment and Recovery Research, NIAAA

CTN Research Update. National Advisory Council on Drug Abuse May 8, Betty Tai, Ph.D. Center for the Clinical Trials Network

State Innovations: Oral Health Integration in Statewide Delivery System and Payment Reform

Behavioral Health Indicators Workgroup: Overview

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

MOBC NIAAA UPDATE Brett Hagman, Ph.D. Robert Huebner, Ph.D. Division of Treatment and Recovery Research, NIAAA

Decline in teen smoking continues into 2012

CABHI- States is a partnership between the Center for Substance Abuse Treatment (CSAT) and Center for Mental Health Services (CMHS) of SAMHSA

Teens and Prescription Drugs:

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

Advancing Behavioral and Social Sciences Research to Meet the Challenges of Obesity and Diabetes

Director s Report to the National Advisory Council on Drug Abuse

Introduction Communities That Care and the Summit County Mental Wellness Alliance

Behavioral Health Barometer. North Dakota, 2013

Submitted electronically to:

Ensuring Access to Mental Health Services For All Chicagoans

Transcription:

NIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, 2015 Nora D. Volkow, M.D., Director

$ (in thousands) NIDA Program Level in Appropriated Dollars and Constant 1998 Dollars 1,200,000 1,000,000 Budget Authority Appropriation in 1998 Dollars 800,000 600,000 400,000 200,000 0 30 Budget is for AIDS research

No. of Applications vs. Awards NIDA Applications, Awards & Success Rates 2500 2000 1500 1000 500 0 Applications Awards Success Rate () 45 40 35 30 25 20 15 10 5 0 Fiscal Year

Percentage of U.S. 12 th Grade Students Reporting Past Month Use of Cigarettes, Marijuana and Alcohol 60 50 40 30 20 10 0 Alcohol Marijuana Cigarettes 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 SOURCE: University of Michigan, 2014 Monitoring the Future Study.

Status of Marijuana Laws in the US

Numbers in Millions Daily Use (Percent) Perceived Risk (Percent) 8 7 6 5 4 3 2 1 0 National Survey on Drug Use and Health (NSDUH) Regular Marijuana Use, Persons Aged 12 or Older: 2002-2012 4.8 + 4.9+ 4.9 + 5.1+ 5.1 + 5.1 + 5.5+ 3.1 + 3.1 + 3.2+ 3.4+ 3.1 + Marijuana on 20 or More Days in Past Month 6.2 + 4.1+ 3.9+ 3.6 + 6.9 + 7.1+ 4.6 + 7.6 5.0 + 5.4 Marijuana on 300 or More Days in Past Year 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Source: National Survey on Drug Use and Health, SAMHSA 12 10 8 6 4 2 0 Monitoring the Future (MTF) 12th Graders Reporting Regular Marijuana Use vs. Perceived Risk of Regular Marijuana Use Perceived Risk Daily Use Source: The Monitoring the Future study, the University of Michigan 90 80 70 60 50 40 30 20 10 0

Subcortical Structures Differences Between Regular Marijuana Users and Nonusers Weiland B J et al. J. Neurosci. 2015;35:1505-1512

Volume (mm 3 ) Effects of Prenatal Nicotine Exposure on Brain Development in Boys and Girls Volume (mm 3 ) Left and Right Pallidum Left Right 2 4 6 8 10 12 14 16 18 20 Age(years) 2 4 6 8 10 12 14 16 18 20 Age(years) Subcortical PC: NIC*Gender interaction p=0.017 (post-hoc interaction: left: p=0.17; right: p=0.68) NIC exposed females had smaller GP than controls, males show no difference Chang et al, PING CONSORTIUM

Adolescent Brain Cognitive Development National Longitudinal Study NIDA, NIAAA, NCI, NICHD, NIMHD, ORWH, OBSSR, NIMH, NINDS, NEI Ten year longitudinal study of 10,000 children from age 10 to 20 years to assess effects of drugs on individual brain development trajectories

Adolescent Brain & Cognitive Development (ABCD) National Longitudinal Study Expert panel workshop developed recommendations on best large-scale designs and measures to assess developmental effects of substance exposure (beginning prior to exposure) during childhood through adolescence (in human subjects) May 27-28, 2014 RFI solicited input on proposed study design/measures June-August 2014 Revised design based on input from RFI and satellite symposium at SfN November 17, 2014 Notices of Intent to Publish: FOA January 2015 Updates at: www.addictionresearch.nih.gov NIDA NIAAA NCI NICHD NIMHD ORWH NIMH NINDS OBSSR NEI

Prospective cohort study of ~10,000 youth beginning ~ ages 9-10 Substance use, Cognition, Emotion, Mental Health, Physical health, Executive Function, General Intelligence, Environment, Biospecimens: Genetics, Epigenetics Time

Notice of Intent to Publish a Funding Opportunity Announcement for A Longitudinal Study of Adolescent Brain and Cognitive Development (ABCD) Research Sites (U01) Notice Number: NOT-DA-15-001 Key Dates Release Date: November 26, 2014 Estimated Publication Date of Announcement: January 2015 First Estimated Application Due Date: April 2015 Earliest Estimated Award Date: September 2015 Earliest Estimated Start Date: September 2015 Related Announcements NOT-DA-15-002 NOT-DA-15-003 Issued by National Institute on Drug Abuse (NIDA) National Cancer Institute (NCI) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Low High Relevant to advancing of knowledge NIDA Strategic Plan 2010-2015 Basic Epi, Prevention Services (HIV) Treatment (HIV) RM&S IRP CTN N Bohr *30 Budget HIV/AIDS Pure basic research without consideration of relevance to practical issues (Current 55) Use-inspired basic research to address important practical questions (Current 10) L Pasteur Waste Pure applied research to address important practical questions (35) T Edison Low High Relevant to immediate application Chalmers et al, Lancet 2014, 383, 9912, 11-17 How to increase value and reduce waste when research priorities are set D E Stokes. Pasteur's quadrant basic science and technological innovation. Brookings Institution Press, Washington, DC (1997)

NIDA Strategic Plan 2010-2015 Current/Future Issues Leveraging new technologies Developing standards, infrastructure, and tools to support Big Data Integration with BRAIN Initiative Responding to changes in SUD landscape (i.e., marijuana policies, healthcare reform, E-cigarettes as drug delivery devices) Accelerate translation research (i.e., medications, devices) Training for next generation of scientists Input from multiple sources - NIDA staff, NIDA Advisory Council, Researchers,Practitioners, Constituent organizations, Consumer groups, Other Stakeholders Key Mechanisms: - Request for Information (RFI)/Public Comment - Bold Goals Challenge Prizes - Priority Area/Cross - Cutting Work Groups Publication: Fall 2015

Updating NIDA Strategic Plan RFI released Dec 10 for feedback on draft priorities: Understanding basic science of drug use, addiction, vulnerability, and recovery Supporting development of new and better interventions and treatments Increasing the public health impact of NIDA research Enhancing the national research infrastructure Comment period closed January 30 th (more than 200 comments) Next steps: Priority Area Workgroups with internal and external experts: Big Data Gene x Environment x Development interactions Complex patients (multiple comorbidities) and phenotyping Health disparities Division strategic plans Timeline RFI Review By March 6, 2015 Priority Area Workgroups Feb-July Division Strategic Plans Drafts By February 6, 2015 Draft Strategic Plan to Council May 2015 Final Strategic Plan Fall 2015